Back
Akero Therapeutics Vs. NetApp Industry Stock Comparison
Buy
62
AKRO
Akero Therapeutics
Last Price:
$49.64
Seasonality Move:
22.68%
Buy
56
NTAP
NetApp
Last Price:
$99.12
Seasonality Move:
6.16%
Buy
62
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.65. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
NTAP Stock Price Chart
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 63.34 | Buy |
Chaikin Money Flow: | 338672 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.2 - 47.04) | Buy |
Bollinger Bands (100): | (33.25 - 50.45) | Buy |
NTAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 59.79 | Buy |
Chaikin Money Flow: | 3282703 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.36 - 100.54) | Buy |
Bollinger Bands (100): | (86.96 - 117.52) | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.53 | Buy |
20-day SMA: | 43.67 | Buy |
50-day SMA: | 41.67 | Buy |
200-day SMA: | 35.37 | Buy |
8-day EMA: | 46.63 | Buy |
20-day EMA: | 44.43 | Buy |
50-day EMA: | 42.76 | Buy |
200-day EMA: | 36.98 | Buy |
NTAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.6 | Sell |
20-day SMA: | 97.75 | Buy |
50-day SMA: | 90.82 | Buy |
200-day SMA: | 112.4 | Sell |
8-day EMA: | 99.31 | Sell |
20-day EMA: | 97.21 | Buy |
50-day EMA: | 95.94 | Buy |
200-day EMA: | 105.45 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
NetApp Earnings Growth & NTAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.74 per share, and an increase next year of $0.53 per share.
Akero Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NetApp Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |